TrialJournal of human hypertension2010

Maintenance of blood-pressure-lowering effect following a missed dose of aliskiren, irbesartan or ramipril: results of a randomized, double-blind study.

P Palatini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.